The Captisol® technology is used to address the limitations of currently marketed drugs. Seven FDA-approved, Captisol-enabled® medications are marketed by: Pfizer, Bristol-Myers Squibb and Baxter International. Captisol® also has License and Supply Agreements (LSAs) in place with a number of pharmaceutical companies worldwide with Captisol-enabled® product candidates. Routes of administration investigated include parenteral, oral, ophthalmic, nasal, topical, oral, and inhalation.

11119 N Torrey Pines Rd Ste 200 La Jolla, CA 92037
Tel: 858-550-7895